SG11202000365QA - Methods and devices for nucleic acid-based real-time determination of disease states - Google Patents

Methods and devices for nucleic acid-based real-time determination of disease states

Info

Publication number
SG11202000365QA
SG11202000365QA SG11202000365QA SG11202000365QA SG11202000365QA SG 11202000365Q A SG11202000365Q A SG 11202000365QA SG 11202000365Q A SG11202000365Q A SG 11202000365QA SG 11202000365Q A SG11202000365Q A SG 11202000365QA SG 11202000365Q A SG11202000365Q A SG 11202000365QA
Authority
SG
Singapore
Prior art keywords
methods
devices
nucleic acid
disease states
time determination
Prior art date
Application number
SG11202000365QA
Inventor
Philip Stevens
Original Assignee
Noscendo Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noscendo Gmbh filed Critical Noscendo Gmbh
Publication of SG11202000365QA publication Critical patent/SG11202000365QA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2535/00Reactions characterised by the assay type for determining the identity of a nucleotide base or a sequence of oligonucleotides
    • C12Q2535/122Massive parallel sequencing
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B35/00ICT specially adapted for in silico combinatorial libraries of nucleic acids, proteins or peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Theoretical Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Medical Informatics (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SG11202000365QA 2017-07-19 2018-07-18 Methods and devices for nucleic acid-based real-time determination of disease states SG11202000365QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17182104.4A EP3431610A1 (en) 2017-07-19 2017-07-19 Methods and devices for nucleic acid-based real-time determination of disease states
PCT/EP2018/069493 WO2019016258A1 (en) 2017-07-19 2018-07-18 Methods and devices for nucleic acid-based real-time determination of disease states

Publications (1)

Publication Number Publication Date
SG11202000365QA true SG11202000365QA (en) 2020-02-27

Family

ID=59387899

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202000365QA SG11202000365QA (en) 2017-07-19 2018-07-18 Methods and devices for nucleic acid-based real-time determination of disease states

Country Status (21)

Country Link
US (1) US11749378B2 (en)
EP (2) EP3431610A1 (en)
JP (1) JP7220711B2 (en)
KR (1) KR102521642B1 (en)
CN (1) CN110914451A (en)
AU (1) AU2018303179A1 (en)
CA (1) CA3069349A1 (en)
DK (1) DK3655540T3 (en)
ES (1) ES2927022T3 (en)
HR (1) HRP20221116T1 (en)
HU (1) HUE059856T2 (en)
IL (1) IL272068A (en)
LT (1) LT3655540T (en)
NZ (1) NZ759783A (en)
PL (1) PL3655540T3 (en)
PT (1) PT3655540T (en)
RS (1) RS63553B1 (en)
RU (1) RU2763969C2 (en)
SG (1) SG11202000365QA (en)
SI (1) SI3655540T1 (en)
WO (1) WO2019016258A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3431610A1 (en) 2017-07-19 2019-01-23 Noscendo GmbH Methods and devices for nucleic acid-based real-time determination of disease states
JP6590417B2 (en) * 2017-11-21 2019-10-16 株式会社バイオーム Discriminating device, discriminating method, discriminating program, discriminating system

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0601302D0 (en) * 2006-01-23 2006-03-01 Semikhodskii Andrei Diagnostic methods and apparatus
GB2477439B (en) 2008-11-07 2012-02-15 Sequenta Inc Methods for correlating clonotypes with a disease in a patient
US9689044B2 (en) * 2011-01-26 2017-06-27 The Brigham And Women's Hospital, Inc. Assays and methods to sequence microbes directly from immune complexes
CN103403186B (en) * 2011-01-26 2015-09-16 雷蒙特亚特特拉维夫大学有限公司 Utilize tiny RNA to check order and cut down and assembling detection infected by microbes
AU2012308092A1 (en) * 2011-09-13 2014-04-17 Commonwealth Scientific And Industrial Research Organisation Detection of viral infection
CN103305607B (en) * 2013-05-22 2015-04-15 宁波大学 Disease prediction method for aquaculture based on microflora change
KR102649364B1 (en) * 2013-11-07 2024-03-20 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 Cell-free nucleic acids for the analysis of the human microbiome and components thereof
JP2017510871A (en) * 2014-01-10 2017-04-13 セブン ブリッジズ ジェノミクス インコーポレイテッド System and method for use of known alleles in read mapping
WO2016127944A1 (en) * 2015-02-10 2016-08-18 The Chinese University Of Hong Kong Detecting mutations for cancer screening and fetal analysis
US10724110B2 (en) 2015-09-01 2020-07-28 Seven Bridges Genomics Inc. Systems and methods for analyzing viral nucleic acids
EP3141612A1 (en) * 2015-09-10 2017-03-15 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Method and device for nucleic acid based diagnostic approaches including the determination of a deviant condtion, especially a health condition and/or pathogenic condition of a sample
CN106636423A (en) * 2017-01-12 2017-05-10 杨俊杰 Analysis method for diversity of oral cavity flora and disease-associated flora marker
EP3431610A1 (en) 2017-07-19 2019-01-23 Noscendo GmbH Methods and devices for nucleic acid-based real-time determination of disease states

Also Published As

Publication number Publication date
KR102521642B1 (en) 2023-04-14
HRP20221116T1 (en) 2022-11-25
EP3655540B1 (en) 2022-08-31
EP3655540A1 (en) 2020-05-27
IL272068A (en) 2020-03-31
EP3431610A1 (en) 2019-01-23
LT3655540T (en) 2022-10-10
US20200176079A1 (en) 2020-06-04
WO2019016258A1 (en) 2019-01-24
KR20200029472A (en) 2020-03-18
JP2020527364A (en) 2020-09-10
NZ759783A (en) 2023-02-24
HUE059856T2 (en) 2023-01-28
PT3655540T (en) 2022-09-20
JP7220711B2 (en) 2023-02-10
RU2020103728A (en) 2021-08-19
RS63553B1 (en) 2022-09-30
RU2020103728A3 (en) 2021-08-19
ES2927022T3 (en) 2022-11-02
PL3655540T3 (en) 2022-10-03
SI3655540T1 (en) 2022-11-30
AU2018303179A1 (en) 2020-01-02
CA3069349A1 (en) 2019-01-24
DK3655540T3 (en) 2022-09-19
RU2763969C2 (en) 2022-01-12
CN110914451A (en) 2020-03-24
US11749378B2 (en) 2023-09-05

Similar Documents

Publication Publication Date Title
HK1249445A1 (en) Anti-sortilin antibodies and methods of use thereof
HK1252693A1 (en) Inhibitors of egfr and methods of use thereof
HK1252698A1 (en) Anti-siglec-9 antibodies and methods of use thereof
IL259495A (en) Antibodies and methods of use thereof
GB201802050D0 (en) Microfluidic devices and methods of use thereof
HK1252696A1 (en) Anti-siglec-7 antibodies and methods of use thereof
SG10201912150TA (en) Anti-trem2 antibodies and methods of use thereof
TWI563574B (en) Finfet devices and methods of forming
IL282572B (en) Tetrahydropyranyl amino-pyrrolopyrimidinone and methods of use thereof
IL267291B (en) Ectonucleotidase inhibitors and methods of use thereof
IL270793A (en) Anti-htra1 antibodies and methods of use thereof
IL265359A (en) Modified oligonucleotides and methods of use
IL272068A (en) Methods and devices for nucleic acid-based real-time determination of disease states
IL274190A (en) Methods of treating an ischemic disease
SG10201912615PA (en) Tetrahydropyranyl amino-pyrrolopyrimidinone and methods of use thereof